Cutler Group’s Amedisys AMED Stock Holding History

Cutler Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-83	Closed	-$3.96K	–	6291
2016 Q4	$3K	Buy	+83	New	+$3.53K	﹤0.01%	5249
2016 Q1	–	Sell	-20,449	Closed	-$789K	–	6414
2015 Q4	$804K	Buy	+20,449	New	+$818K	0.04%	410

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's AMED Position: Q1 2017 in Review

Cutler Group sold out of Amedisys (AMED) in Q1 2017, closing a stake of 83 shares — an estimated $3.96K sold.

Cutler Group first reported a position in AMED in Q4 2015 and held it in 2 quarters. The position peaked at $804K in Q4 2015. 152 funds tracked by Wall St. Rank hold AMED as of Q1 2017.

Cutler Group reported no remaining Amedisys position as of Q1 2017 after selling out during the quarter.
Cutler Group sold 83 Amedisys shares in Q1 2017, an estimated $3.96K.
Cutler Group first reported a position in Amedisys in Q4 2015 and held it in 2 quarters.
Cutler Group's Amedisys position peaked at $804K in Q4 2015.
152 funds tracked by Wall St. Rank held Amedisys as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.